Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Department of Cardiology, Alfried-Krupp Hospital, Essen, Germany.
AIDS Res Hum Retroviruses. 2024 Apr;40(4):235-245. doi: 10.1089/AID.2023.0055. Epub 2023 Oct 9.
Traditional cardiovascular risk scores underestimate the incidence of cardiovascular diseases (CVD) in people living with HIV (PLH). This study compared the effect of HIV-specific cardiovascular risk factors (CRF) with traditional CRF at baseline for their association with incident CVD in PLH. The ongoing, prospective HIV HEART Aging (HIVH) study assesses CVD in PLH in the German Ruhr Area since 2004. PLH from the HIVH study with at least 5 years of follow-up were examined with the help of Cox proportional hazards models using inverse probability-of-censoring weights. The models were adjusted for age and sex. The obtained hazard ratios (HR) and 95% confidence limits (CL) assessed the strength of the associations between CRF and CVD. One thousand two hundred forty-three individuals (male 1,040, female 203; mean age of 43 ± 10 years) with 116 incident CVD events were analyzed. After adjusting for the traditional CRF, the HIV-specific CRF "a history of AIDS" and "higher age at diagnosis of HIV infection" (per 10 years) were associated with an increased CVD risk (HR 1.55, 95% CL: 1.05-2.28 and HR 1.55, 95% CL: 1.09-1.22, respectively). Higher CD4/CD8 ratio (per standard deviation), longer cumulative duration of antiretroviral therapies, and longer duration of HIV infection (per 10 years) showed indications for a decreased CVD risk (HR 0.75, 95% CL: 0.58-0.97, HR 0.71, 95% CL: 0.41-1.23, and HR 0.63, 95% CL: 0.44-0.90, respectively). Out of the traditional CRF, current smoking showed the strongest impact on CVD risk (HR 3.12, 95% CL: 2.06-4.74). In conclusion, HIV-specific factors, such as history of AIDS and CD4/CD8 ratio, were independently associated with an increased cardiovascular risk. Traditional CRF maintained a major effect on CVD. Clinical Trials Number (NCT04330287).
传统的心血管风险评分低估了 HIV 感染者(PLH)发生心血管疾病(CVD)的风险。本研究比较了 HIV 特异性心血管危险因素(CRF)与传统 CRF 在基线时对 PLH 发生 CVD 的影响。自 2004 年以来,正在进行的前瞻性 HIV HEART Aging(HIVH)研究一直在德国鲁尔地区评估 PLH 的 CVD 情况。在 HIVH 研究中,至少有 5 年随访的 PLH 患者使用逆概率删失加权的 Cox 比例风险模型进行了检查。模型根据年龄和性别进行了调整。获得的风险比(HR)和 95%置信区间(CL)评估了 CRF 与 CVD 之间的关联强度。共分析了 1243 名个体(男性 1040 名,女性 203 名;平均年龄 43±10 岁),其中有 116 例发生 CVD 事件。在调整了传统的 CRF 后,HIV 特异性 CRF“艾滋病史”和“HIV 感染诊断时年龄较大”(每增加 10 岁)与 CVD 风险增加相关(HR 1.55,95%CL:1.05-2.28 和 HR 1.55,95%CL:1.09-1.22)。更高的 CD4/CD8 比值(每标准差)、更长的累积抗逆转录病毒治疗持续时间和更长的 HIV 感染持续时间(每增加 10 年)显示出降低 CVD 风险的迹象(HR 0.75,95%CL:0.58-0.97,HR 0.71,95%CL:0.41-1.23,HR 0.63,95%CL:0.44-0.90)。在传统的 CRF 中,目前吸烟对 CVD 风险的影响最大(HR 3.12,95%CL:2.06-4.74)。总之,HIV 特异性因素,如艾滋病史和 CD4/CD8 比值,与心血管风险增加独立相关。传统的 CRF 对 CVD 仍有重大影响。临床试验编号(NCT04330287)。